Beyond Basic Beta Content Hub Assessing Political Outcomes for Pharmaceuticals ETFs By Tom LydonJuly 21, 2020
Beyond Basic Beta Content Hub Big Biotech Stands Tall Amid Race for Virus Vaccine By Tom LydonJuly 17, 2020
Beyond Basic Beta Content Hub Increasing International Allure for Green Bonds By Tom LydonJuly 16, 2020
Beyond Basic Beta Content Hub Favorable Case for VanEck Esports ETF Continues Mounting By Tom LydonJuly 15, 2020
Beyond Basic Beta Content Hub Muni Bonds Could be Bolstered by Interesting Revenue Stream By Tom LydonJuly 13, 2020
Beyond Basic Beta Content Hub This Healthcare ETF Is Nifty Virus Play, but not in Usual Way By Tom LydonJuly 9, 2020
Beyond Basic Beta Content Hub There Are Some Risks, but Opportunities Remain With BDC ETF By Tom LydonJuly 7, 2020
Beyond Basic Beta Content Hub If Internet Giants Avoid Controversy, XLC Is a Winner By Tom LydonJune 29, 2020
Beyond Basic Beta Content Hub This High-Yield ETF Is a Fine Compliment to Income-Generating Portfolios By Tom LydonJune 26, 2020
Beyond Basic Beta Content Hub Fall of the Triple B’s Gives Rise to This High-Yield ETF By Tom LydonJune 25, 2020
